1. JaattelaM, MouritzenH, EllingF, BastholmL (1996) A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 156: 1166–1173.
2. LeeEG, BooneDL, ChaiS, LibbySL, ChienM, et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350–2354.
3. BooneDL, TurerEE, LeeEG, AhmadRC, WheelerMT, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: 1052–1060.
4. HitotsumatsuO, AhmadRC, TavaresR, WangM, PhilpottD, et al. (2008) The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28: 381–390.
5. TavaresRM, TurerEE, LiuCL, AdvinculaR, ScapiniP, et al. (2010) The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33: 181–191.
6. ChuY, VahlJC, KumarD, HegerK, BertossiA, et al. (2011) B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117: 2227–2236.
7. HovelmeyerN, ReissigS, XuanNT, Adams-QuackP, LukasD, et al. (2011) A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 41: 595–601.
8. HammerGE, TurerEE, TaylorKE, FangCJ, AdvinculaR, et al. (2011) Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 12: 1184–1193.
9. YangW, TangH, ZhangY, TangX, ZhangJ, et al. (2013) Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet 92: 41–51.
10. JostinsL, RipkeS, WeersmaRK, DuerrRH, McGovernDP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119–124.
11. Genetic Analysis of PsoriasisC, the Wellcome Trust Case ControlC, StrangeA, CaponF, SpencerCC, et al. (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42: 985–990.
12. KochiY, OkadaY, SuzukiA, IkariK, TeraoC, et al. (2010) A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 42: 515–519.
13. StahlEA, RaychaudhuriS, RemmersEF, XieG, EyreS, et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42: 508–514.
14. DuboisPC, TrynkaG, FrankeL, HuntKA, RomanosJ, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295–302.
15. HanJW, ZhengHF, CuiY, SunLD, YeDQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234–1237.
16. NairRP, DuffinKC, HelmsC, DingJ, StuartPE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199–204.
17. GrahamRR, CotsapasC, DaviesL, HackettR, LessardCJ, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: 1059–1061.
18. PlengeRM, CotsapasC, DaviesL, PriceAL, de BakkerPI, et al. (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39: 1477–1482.
19. CompagnoM, LimWK, GrunnA, NandulaSV, BrahmacharyM, et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459: 717–721.
20. KatoM, SanadaM, KatoI, SatoY, TakitaJ, et al. (2009) Frequent inactivation of A20 in B-cell lymphomas. Nature 459: 712–716.
21. HonmaK, TsuzukiS, NakagawaM, TagawaH, NakamuraS, et al. (2009) TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 114: 2467–2475.
22. ChanudetE, HuangY, IchimuraK, DongG, HamoudiRA, et al. (2010) A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 24: 483–487.
23. SchmitzR, HansmannML, BohleV, Martin-SuberoJI, HartmannS, et al. (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206: 981–989.
24. VaughnSE, KottyanLC, MunroeME, HarleyJB (2012) Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. J Leukoc Biol 92: 577–591.
25. GuerraSG, VyseTJ, Cunninghame GrahamDS (2012) The genetics of lupus: a functional perspective. Arthritis Res Ther 14: 211.
26. MusoneSL, TaylorKE, LuTT, NitithamJ, FerreiraRC, et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40: 1062–1064.
27. AdriantoI, WenF, TempletonA, WileyG, KingJB, et al. (2011) Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 43: 253–258.
28. DieudeP, GuedjM, WipffJ, RuizB, RiemekastenG, et al. (2010) Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 69: 1958–1964.
29. KoumakisE, GiraudM, DieudeP, CohignacV, CuomoG, et al. (2012) Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum 64: 2746–2752.
30. ShimaneK, KochiY, HoritaT, IkariK, AmanoH, et al. (2010) The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum 62: 574–579.
31. MusoneSL, TaylorKE, NitithamJ, ChuC, PoonA, et al. (2011) Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes Immun 12: 176–182.
32. SiggersT, ChangAB, TeixeiraA, WongD, WilliamsKJ, et al. (2012) Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nat Immunol 13: 95–102.
33. Kohwi-ShigematsuT, KohwiY, TakahashiK, RichardsHW, AyersSD, et al. (2012) SATB1-mediated functional packaging of chromatin into loops. Methods 58: 243–254.
34. CaiS, LeeCC, Kohwi-ShigematsuT (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278–1288.
35. AinbinderE, Amir-ZilbersteinL, YamaguchiY, HandaH, DiksteinR (2004) Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB. Mol Cell Biol 24: 2444–2454.
36. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
37. NairRP, DuffinKC, HelmsC, DingJ, StuartPE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199–204.
38. ThomsonW, BartonA, KeX, EyreS, HinksA, et al. (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39: 1431–1433.
39. TrynkaG, ZhernakovaA, RomanosJ, FrankeL, HuntKA, et al. (2009) Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 58: 1078–1083.
40. HagegeH, KlousP, BraemC, SplinterE, DekkerJ, et al. (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2: 1722–1733.
41. DekkerJ (2006) The three ‘C’ s of chromosome conformation capture: controls, controls, controls. Nat Methods 3: 17–21.